- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07347847
Impact on Mortality of Hospitalisation of a Patient in a Hospital Bed That Does Not Correspond to His Needs After a Visit to the Emergency Department (RIGHT BED)
January 16, 2026 updated by: Rennes University Hospital
The aim of this study is to assess the impact of hospitalisation outside the referral requested by the emergency doctor on the mortality of patients admitted to emergency departments.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
2766
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: François Saget, Md
- Phone Number: +33299284321
- Email: francois.saget@chu-rennes.fr
Study Locations
-
-
-
Angers, France
- CHU Angers
-
Principal Investigator:
- Delphine Douillet
-
Contact:
- Delphine DOUILLET
- Phone Number: +33241353637
- Email: delphine.douillet@chu-angers.fr
-
Le Mans, France
- CH Le Mans
-
Contact:
- Lionel Imsaad
- Phone Number: +332 43 43 43 43
- Email: limsaad@ch-lemans.fr
-
Principal Investigator:
- Lionel Imsaad
-
Nantes, France
- CHU Nantes
-
Principal Investigator:
- Emmanuel Montassier
-
Contact:
- Emmanuel Montassier
- Phone Number: +332 40 08 33 33
- Email: Emmanuel.MONTASSIER@chu-nantes.fr
-
Poitiers, France
- CHU Poitiers
-
Principal Investigator:
- Nicolas MARJANOVIC
-
Contact:
- Nicolas Marjanovic
- Phone Number: +330549444444
- Email: nicolas.marjanovic@chu-poitiers.fr
-
Strasbourg, France
- CHU Strasbourg
-
Contact:
- Pierrick Le Borgne
- Phone Number: +333 88 11 67 68
- Email: pierrick_med@yahoo.fr
-
Principal Investigator:
- Pierrick Le Borgne
-
Toulouse, France
- Chu Toulouse
-
Contact:
- Margaux Piechowiak
- Phone Number: +335 61 77 22 33
- Email: Piechowiak.m@chu-toulouse.fr
-
Principal Investigator:
- Margaux Piechowiak
-
Tours, France
- CHU Tours
-
Contact:
- Geoffroy Rousseau
- Phone Number: +332.47.47.47.47
- Email: geoffroy.rousseau@chu-tours.fr
-
Principal Investigator:
- Geoffroy Rousseau
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
- People Presenting at an emergency department
Description
Inclusion Criteria:
- Presenting at an emergency department participating in the study,
- Requiring hospitalisation
Exclusion Criteria:
- Patients hospitalised in short-stay units with secondary outpatient care,
- Adults subject to legal protection (legal guardianship, curatorship, trusteeship), persons deprived of their liberty.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Death rate
Time Frame: 30 days
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of hospitalization
Time Frame: 30 days
|
30 days
|
|
|
length of stay in the emergency department
Time Frame: 30 days
|
30 days
|
|
|
Rate of Adverse events
Time Frame: 30 days
|
Adverse events occuring during hospitalization
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: François Saget, francois.saget@chu-rennes.fr
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Study Registration Dates
First Submitted
January 8, 2026
First Submitted That Met QC Criteria
January 8, 2026
First Posted (Actual)
January 16, 2026
Study Record Updates
Last Update Posted (Actual)
January 21, 2026
Last Update Submitted That Met QC Criteria
January 16, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 35RC25_30013
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.